SEC filings
Humana (HUM)
Recent filings Humana made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0000049071All filings on SEC.gov
8-KCurrent report
Regulation FD Disclosure
Humana has entered a new joint venture with funds and accounts managed by HPS Investment Partners, a BlackRock subsidiary, to manage and operate roughly 150 CenterWell Senior Primary Care clinics, replacing its existing joint ventures with…
8-KCurrent report
Regulation FD Disclosure
Humana said that, based on final 2027 Medicare Advantage Star Ratings data (Bonus Year 2028) provided by CMS, it exceeded its goal of top-quartile results, defined as Stars revenue per member per month 10% above the peer group median, and…
8-KCurrent report
Regulation FD Disclosure
Humana senior management plans to meet with investors and analysts between September 1 and September 30, 2026, and intends to reaffirm its FY 2026 guidance of at least $6.52 in GAAP diluted EPS or at least $9.00 in adjusted EPS, consistent…
10-QQuarterly report
Quarterly report
Humana reported second-quarter 2026 net income attributable to the company of $694 million, or $5.73 per diluted share, up from $545 million, or $4.51 per diluted share, a year earlier, and first-half 2026 net income of $1.9 billion versus…
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Humana expanded its board of directors from eleven to thirteen members and elected Paul Smith, chief commercial officer at Anthropic, and Frederick Crawford, formerly president and chief operating officer of Aflac, as independent directors…
8-KCurrent report
Results of Operations and Financial Condition; Regulation FD Disclosure
Humana reported second-quarter 2026 GAAP diluted EPS of $5.73 and Adjusted EPS of $7.61, and said it affirmed full-year 2026 Adjusted EPS guidance of at least $9.00 while revising GAAP EPS guidance to at least $6.52 from at least $8.36. …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Humana in Readster
Add Humana to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.